GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $2.57 million. The enterprise value is -$3.79 million.

Market Cap	2.57M
Enterprise Value	-3.79M

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 2.93 million shares outstanding. The number of shares has increased by 1,574.64% in one year.

Shares Outstanding	2.93M
Shares Change (YoY)	+1,574.64%
Shares Change (QoQ)	+44.17%
Owned by Insiders (%)	0.27%
Owned by Institutions (%)	0.78%
Float	2.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.14
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.03.

Current Ratio	3.11
Quick Ratio	2.87
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -189.06% and return on invested capital (ROIC) is -117.00%.

Return on Equity (ROE)	-189.06%
Return on Assets (ROA)	-82.53%
Return on Capital (ROIC)	-117.00%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-99.17%
50-Day Moving Average	0.53
200-Day Moving Average	5.76
Relative Strength Index (RSI)	59.13
Average Volume (20 Days)	10,819,368

Short Selling Information

The latest short interest is 225,823, so 7.71% of the outstanding shares have been sold short.

Short Interest	225,823
Short Previous Month	169,124
Short % of Shares Out	7.71%
Short % of Float	8.51%
Short Ratio (days to cover)	0.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.37M
Pretax Income	-12.77M
Net Income	-8.28M
EBITDA	-8.36M
EBIT	-8.37M
Earnings Per Share (EPS)	-$31.86

Full Income Statement

Balance Sheet

The company has $6.35 million in cash and $141,000 in debt, giving a net cash position of $6.21 million or $2.12 per share.

Cash & Cash Equivalents	6.35M
Total Debt	141,000
Net Cash	6.21M
Net Cash Per Share	$2.12
Equity (Book Value)	4.72M
Book Value Per Share	5.88
Working Capital	4.67M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.22M
Capital Expenditures	n/a
Free Cash Flow	-11.22M
FCF Per Share	-$3.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,574.64%
Shareholder Yield	-1,574.64%
Earnings Yield	-341.89%
FCF Yield	-463.20%

Analyst Forecast

The average price target for GRI Bio is $12.00, which is 1,266.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	1,266.74%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 18, 2024. It was a reverse split with a ratio of 0.0769231:1.

Last Split Date	Jun 18, 2024
Split Type	Reverse
Split Ratio	0.0769231:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a